Citius Pharmaceuticals, Inc. (CTXR) short interest & options flow
NASDAQCTXR short interest climbs 20.7% over one week to 28.6% of float, while cost to borrow doubles to 95.7% — highest in months as availability plummets.
- Market cap
- $13M
- Next earnings
- 23 Dec 2026
Key data as of 12 Nov 2026
Latest signals on CTXR
- Short Interest
CTXR short interest climbs 20.7% over one week to 28.6% of float, while cost to borrow doubles to 95.7% — highest in months as availability plummets.
- Options
CTXR put/call ratio surges to 0.0702, a 4.1 standard deviations above the 20-day average of 0.0295—signaling extreme call buying as the biotech stock plummets 24.8% in a single day following earnings miss.
- Utilization
CTXR utilisation surges to 99% on April 23, matching its 52-week high of 100% — up sharply from 78.65% the previous day.
CTXR news and analysis
RSSNo long-form analysis yet for CTXR. Pulse alerts and the live data picture are available on ORTEX.
Open CTXR on ORTEX →Want the live picture for CTXR?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CTXR — free to start on ORTEX.
Sign up for free →Open CTXR on ORTEX